Lymph Node Mapping in Patients With Endometrial Cancer

NACompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 16, 2016

Study Completion Date

March 31, 2017

Conditions
Endometrial Cancer
Interventions
PROCEDURE

sentinel lymph node detection

Undergo sentinel lymph node detection using fluorescence imaging with indocyanine green solution and isosulfan blue

DRUG

indocyanine green solution

Undergo sentinel lymph node detection using fluorescence imaging with indocyanine green solution and isosulfan blue

DRUG

isosulfan blue

Undergo sentinel lymph node detection using fluorescence imaging with indocyanine green solution and isosulfan blue

PROCEDURE

sentinel lymph node biopsy

Undergo sentinel lymph node biopsy

Trial Locations (2)

43210

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

06520

Smilow Cancer Hospital at Yale New Haven, New Haven

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT01818739 - Lymph Node Mapping in Patients With Endometrial Cancer | Biotech Hunter | Biotech Hunter